EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

From geroscience to precision geromedicine: Understanding and managing aging

Guido Kroemer, Andrea B Maier, Ana Maria Cuervo, Vadim N Gladyshev, Luigi Ferrucci, Vera Gorbunova, Brian K Kennedy, Thomas A Rando, Andrei Seluanov, Felipe Sierra, Eric Verdin, Carlos López-Otín

Cell · 2025-04 · 188 (8) · 2043-2062

DOI: 10.1016/j.cell.2025.03.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell, 2025-04. Verfasst von Guido Kroemer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris,…. Hauptthemen laut MEDLINE: Aging, Precision Medicine, Geroscience, Geriatrics. Die Arbeit wurde bisher 428-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAMS NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major progress has been made in elucidating the molecular, cellular, and supracellular mechanisms underlying aging. This has spurred the birth of geroscience, which aims to identify actionable hallmarks of aging. Aging can be viewed as a process that is promoted by overactivation of gerogenes, i.e., genes and molecular pathways that favor biological aging, and alternatively slowed down by gerosuppressors, much as cancers are caused by the activation of oncogenes and prevented by tumor suppressors. Such gerogenes and gerosuppressors are often associated with age-related diseases in human population studies but also offer targets for modeling age-related diseases in animal models and treating or preventing such diseases in humans. Gerogenes and gerosuppressors interact with environmental, behavioral, and psychological risk factors to determine the heterogeneous trajectory of biological aging and disease manifestation. New molecular profiling technologies enable the characterization of gerogenic and gerosuppressive pathways, which serve as biomarkers of aging, hence inaugurating the era of precision geromedicine. It is anticipated that, pending results from randomized clinical trials and regulatory approval, gerotherapeutics will be tailored to each person based on their genetic profile, high-dimensional omics-based biomarkers of aging, clinical and digital biomarkers of aging, psychosocial profile, and past or present exposures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingPrecision MedicineGeroscienceGeriatricsHumansAnimals

Stichwörter der Autor:innen

agingaging clocksanti-aging drugsatherosclerosiscancercardiovascular diseasesdiabetesepigenetic clocksgenomicsneurodegenerationoncogeneoncosuppressionprimary prevention

Autor:innen und Institutionen

  • Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Inserm U1138, Université Paris Cité, Sorbonne Université, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy Insti…
  • Department of Human Movement Sciences, @AgeAmsterdam, Faculty of Behavioural and Movement Sciences, Vrije Universiteit, Amsterdam Movement Sciences, Amsterdam, the Netherlands; NUS Academy for Healthy Longevity, Yong Lo…
  • Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA; Institute for Aging Research, Albert Einstein College of Medicine, Bronx, New York, NY, USA; Depart…
  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Translational Gerontology Branch, National Institute on Aging Intramural Research Program, Baltimore, MD, USA.
  • Department of Biology, University of Rochester, Rochester, NY, USA; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.

Förderung

  • NIA NIH HHS
  • NIAMS NIH HHS
  • Intramural NIH HHS
  • Wellcome Trust
  • National Medical Research Council
  • French National Cancer Institute
  • Lien Foundation
  • Equipex

Zitieren

APA

Kroemer, G., Maier, A. B., Cuervo, A. M., Gladyshev, V. N., Ferrucci, L., Gorbunova, V., Kennedy, B. K., Rando, T. A., Seluanov, A., Sierra, F., Verdin, E., & López-Otín, C. (2025). From geroscience to precision geromedicine: Understanding and managing aging. Cell, 188(8), 2043-2062. https://doi.org/10.1016/j.cell.2025.03.011

Vancouver

Kroemer G, Maier AB, Cuervo AM, Gladyshev VN, Ferrucci L, Gorbunova V, et al. From geroscience to precision geromedicine: Understanding and managing aging. Cell. 2025;188(8):2043-2062. doi:10.1016/j.cell.2025.03.011

BibTeX
@article{Kroemer2025,
  author = {Kroemer, Guido and Maier, Andrea B and Cuervo, Ana Maria and Gladyshev, Vadim N and Ferrucci, Luigi and Gorbunova, Vera and Kennedy, Brian K and Rando, Thomas A and Seluanov, Andrei and Sierra, Felipe and Verdin, Eric and López-Otín, Carlos},
  title = {From geroscience to precision geromedicine: Understanding and managing aging},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {8},
  pages = {2043--2062},
  doi = {10.1016/j.cell.2025.03.011}
}
Kostenlos starten →